Answer
Yes, anaphylactic reactions have been reported with efgartigimod alfa in the post-marketing setting.
Sources for this answer
- Vyvgart 20 mg/mL concentrate for solution for infusionArgenx UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked